how will rdca-dap® support patient-focused drug development?
Published 2 years ago • 187 plays • Length 3:00Download video MP4
Download video MP3
Similar videos
-
58:09
patient focused drug development - how rdca-dap can help
-
3:37
what is patient-focused drug development (pfdd)?
-
4:17
rdca-dap: shortening the timeline for developing new treatments for rare diseases
-
48:02
rdca-dap - value of integrated data and analytics in rare disease drug development
-
58:44
shortening the timeline for developing new treatments - how the rdca-dap can help
-
8:03
rdca-dap: how the data and analytics platform accelerates rare disease drug development
-
2:05
how can patients and advocates help accelerate drug development?
-
1:36:06
webinar: rdca-dap and eatris present rare disease drug development
-
21:28
how do you write a regulatory pathway analysis?
-
10:09
how state management works in dapr!
-
14:13
psychodermatology: more than skin deep | linda papadopoulos | tedxuniversityofmanchester
-
55:49
sharing data with rdca-dap: your questions answered
-
31:11
from data to cures: speeding the way for rare diseases
-
3:44
rare disease challenges in each step of the drug development process
-
1:50
rare disease drug development education series trailer
-
1:34:43
eatx rdca-dap - webinar on ‘data sharing and analysis to support rare disease drug development‘
-
56:43
how patient nonprofits can help accelerate drug development
-
12:03
rdca-dap drug development tool prototypes
-
38:32
rdca-dap launch live stream - am part 1
-
57:50
drug development for rare diseases: a community conversation
-
59:23
what does patient focused drug development look like for rare diseases sd 480p